Table 2.

Correlations between transplantation rate and clinicopathological parameters of all patients

Clinicopathological features	No. of patients (%)	Successful engraftment (%)	P
Gender			0.404
Female	10 (19.2%)	5 (50.0%)
Male	42 (80.8%)	15 (35.7%)
Age (years)			0.264
<60	31 (59.6%)	10 (32.3%)
≥60	21 (40.4%)	10 (47.6%)
Tumor type			0.079
Primary tumor (HCC and CRC)	36 (69.2%)	11 (30.6%)
MLC	16 (30.8%)	9 (56.3%)
Smoking history			0.350
No	35 (67.3%)	15 (42.9%)
Yes	17 (32.7%)	5 (29.4%)
History of alcohol consumption			1.000
No	39 (75.0%)	15 (38.5%)
Yes	13 (25.0%)	5 (38.5%)
Tumor size (cm)			0.143
<5.2	30 (57.7%)	9 (30.0%)
≥5.2	22 (42.3%)	11 (50.0%)
Blood type			0.008**
O	13 (25.0%)	9 (69.2%)
Non-O (A, B, and AB)	39 (76.0%)	11 (28.2%)
Vascular invasion			0.924
No	36 (69.2%)	14 (38.9%)
Yes	16 (30.8%)	6 (37.5%)
Perineuronal invasion			1.000
No	30 (57.7%)	10 (33.3%)
Yes	3 (5.8%)	1 (33.3%)
NA	19 (11.5%)	9 (47.4%)
Differentiation			0.583
Moderate	32 (61.6%)	11 (34.4%)
Poor	14 (26.9%)	6 (42.9%)
NA	6 (11.5%)	3 (50.0%)
TNM stage			0.008**
I-II	25 (48.1%)	5 (20.0%)
III-IV	27 (51.9%)	15 (55.6%)
Lymph node metastasis			0.120
Present	17 (32.7%)	9 (52.9%)
Absent	30 (57.7%)	9 (30.0%)
NA	5 (9.6%)	2 (40.0%)
Distant metastasis			0.102
Present	17 (32.7%)	9 (52.9%)
Absent	31 (59.6%)	9 (29.0%)
NA	4 (7.7%)	2 (50.0%)
CEA (0-5 ng/ml)			0.015*
Normal	34 (65.4%)	9 (26.5%)
Abnormal	18 (34.6%)	11 (61.1%)
CA19-9 (0-37 U/ml)			0.017*
Normal	29 (55.8%)	7 (24.1%)
Abnormal	23 (44.2%)	13 (56.5%)
CA72.4 (0-6.7 U/ml)			0.264
Normal	31 (59.6%)	13 (41.9%)
Abnormal	21 (40.4%)	7 (33.3%)
CA242 (0-20 U/ml)			0.135
Normal	35 (67.3%)	11 (31.4%)
Abnormal	17 (32.7%)	9 (52.9%)

CRC, colorectal carcinoma; HCC, hepatocellular carcinoma; MLC, metastatic liver cancer; NA, not available;

*p<0.05, **p<0.01. Chi-square test.